REGISTERED CHARITY NUMBER: 1017576
Report of the Trustees and
Unaudited Financial Statements for the Year Ended 31 March 2025
for
Cystic Fibrosis Comfort Fund
Monahans Chartered Accountants Lennox House
3 Pierrepont Street Bath Somerset BA1 1LB
Cystic Fibrosis Comfort Fund
Contents of the Financial Statements for the Year Ended 31 March 2025
| Page | |||
|---|---|---|---|
| Report of the Trustees | 1 | ||
| Independent Examiner's Report | 2 | ||
| Statement of Financial Activities | 3 | ||
| Balance Sheet | 4 | ||
| Notes to the Financial Statements | 5 | to | 7 |
| Detailed Statement of Financial Activities | 8 |
Cystic Fibrosis Comfort Fund
Report of the Trustees for the Year Ended 31 March 2025
The trustees submit their report for the year ended 31 March 2025.
OBJECTIVES AND ACTIVITIES
Objects and Aims of the Charity
To relieve those persons suffering from Cystic Fibrosis and to assist the families of those persons who are in conditions of need, hardship or distress.
ACHIEVEMENTS AND PERFORMANCE
Results for the Year
The trustees recorded a surplus of £49,113 for the year (2024: deficit £6,263).
FINANCIAL REVIEW
During the year a generous one-off donation of £55,054 was received from the estate of one of our kind donors.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, a deed of trust and constitutes an unincorporated charity.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Charity number
1017576
Principal address
17 Filton Avenue Horfield Bristol BS7 0AQ
Trustees
K Badlan M Burridge (deceased 25.1.25) K Wedlock K Lindsay J Smith L Nichols T Modzelewski K A Harriman S B Brennan (appointed 12.4.25)
Independent Examiner
Robert Branch Monahans Chartered Accountants Lennox House 3 Pierrepont Street Bath Somerset BA1 1LB
Approved by order of the board of trustees on ............................................. and signed on its behalf by:
........................................................................ K Badlan - Trustee
Page 1
Independent Examiner's Report to the Trustees of Cystic Fibrosis Comfort Fund
Independent examiner's report to the trustees of Cystic Fibrosis Comfort Fund
I report to the charity trustees on my examination of the accounts of Cystic Fibrosis Comfort Fund (the Trust) for the year ended 31 March 2025.
Responsibilities and basis of report
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or 2. the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Robert Branch
Monahans Chartered Accountants Lennox House 3 Pierrepont Street Bath Somerset BA1 1LB
Date: .............................................
Page 2
Cystic Fibrosis Comfort Fund
Statement of Financial Activities for the Year Ended 31 March 2025
| 2025 Unrestricted fund Notes £ INCOME AND ENDOWMENTS FROM Donations and legacies 68,467 Investment income 2 1,285 Total 69,752 EXPENDITURE ON Charitable activities Support to persons suffering Cystic Fibrosis and to their families 20,553 Other 86 Total 20,639 NET INCOME/(EXPENDITURE) 49,113 RECONCILIATION OF FUNDS Total funds brought forward 120,586 TOTAL FUNDS CARRIED FORWARD 169,699 |
2024 Total funds £ 4,434 1,030 5,464 11,669 58 11,727 (6,263) 126,849 120,586 |
|---|---|
The notes form part of these financial statements
Page 3
Cystic Fibrosis Comfort Fund
Balance Sheet
31 March 2025
| 2025 Unrestricted fund Notes £ CURRENT ASSETS Debtors 5 643 Cash at bank 170,152 170,795 CREDITORS Amounts falling due within one year 6 (1,096) NET CURRENT ASSETS 169,699 TOTAL ASSETS LESS CURRENT LIABILITIES 169,699 NET ASSETS 169,699 FUNDS 7 Unrestricted funds 169,699 TOTAL FUNDS 169,699 |
2024 Total funds £ 675 120,946 121,621 (1,035) 120,586 120,586 120,586 120,586 120,586 |
|---|---|
The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by:
............................................. K Badlan - Trustee
The notes form part of these financial statements
Page 4
Cystic Fibrosis Comfort Fund
Notes to the Financial Statements for the Year Ended 31 March 2025
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.
Taxation
The charity is exempt from tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
2. INVESTMENT INCOME
| INVESTMENT INCOME | ||
|---|---|---|
| 2025 | 2024 | |
| £ | £ | |
| Investment Income | 1,285 | 1,030 |
3.
TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024.
4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
| INCOME AND ENDOWMENTS FROM | Unrestricted fund £ |
|---|---|
| Donations and legacies | 4,434 |
| Investment income | 1,030 |
| Total | 5,464 |
| EXPENDITURE ON | |
| Charitable activities | |
| Support to persons suffering Cystic Fibrosis | |
| and to their families | 11,669 |
| Other | 58 |
| Total | 11,727 |
Page 5
continued...
Cystic Fibrosis Comfort Fund
Notes to the Financial Statements - continued for the Year Ended 31 March 2025
4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
| NET INCOME/(EXPENDITURE) RECONCILIATION OF FUNDS Total funds brought forward TOTAL FUNDS CARRIED FORWARD 5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Other debtors 6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Other creditors 7. MOVEMENT IN FUNDS Unrestricted funds General fund TOTAL FUNDS Net movement in funds, included in the above are as follows: Unrestricted funds General fund TOTAL FUNDS Comparatives for movement in funds Unrestricted funds General fund TOTAL FUNDS |
At 1.4.24 £ 120,586 120,586 Incoming resources £ 69,752 69,752 At 1.4.23 £ 126,849 126,849 |
Unrestricted fund £ (6,263) 126,849 120,586 2025 2024 £ £ 643 675 2025 2024 £ £ 1,096 1,035 Net movement At in funds 31.3.25 £ £ 49,113 169,699 49,113 169,699 Resources Movement expended in funds £ £ (20,639) 49,113 (20,639) 49,113 Net movement At in funds 31.3.24 £ £ (6,263) 120,586 (6,263) 120,586 |
|---|---|---|
Page 6
continued...
Cystic Fibrosis Comfort Fund
Notes to the Financial Statements - continued for the Year Ended 31 March 2025
7. MOVEMENT IN FUNDS - continued
Comparative net movement in funds, included in the above are as follows:
| Incoming resources £ Unrestricted funds General fund 5,464 TOTAL FUNDS 5,464 A current year 12 months and prior year 12 months combined position is as follows: At 1.4.23 £ Unrestricted funds General fund 126,849 TOTAL FUNDS 126,849 |
Resources Movement expended in funds £ £ (11,727) (6,263) (11,727) (6,263) Net movement At in funds 31.3.25 £ £ 42,850 169,699 42,850 169,699 |
|---|---|
A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:
| Unrestricted funds | Incoming Resources resources expended £ £ |
Movement in funds £ |
|---|---|---|
| General fund | 75,216 (32,366) |
42,850 |
| TOTAL FUNDS | 75,216 (32,366) |
42,850 |
8. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 31 March 2025.
Page 7
Cystic Fibrosis Comfort Fund
Detailed Statement of Financial Activities for the Year Ended 31 March 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| INCOME AND ENDOWMENTS | ||
| Donations and legacies | ||
| Gifts and Donations | 13,413 | 4,434 |
| Legacies | 55,054 | - |
| Investment income | 68,467 | 4,434 |
| Investment Income | 1,285 | 1,030 |
| Total incoming resources | 69,752 | 5,464 |
| EXPENDITURE | ||
| Charitable activities | ||
| Advertising | 501 | - |
| Support to persons suffering Cystic Fibrosis and | ||
| to their families | 8,687 | 6,502 |
| Grants to individuals | 8,000 | 3,250 |
| Support costs | 17,188 | 9,752 |
| Management | ||
| Telephone | 314 | 415 |
| Postage and stationery | 424 | 396 |
| Sundries | - | 80 |
| Conference & Travel costs | 1,840 | 40 |
| Website costs | 71 | 300 |
| Finance | 2,649 | 1,231 |
| Bank charges | 15 | 15 |
| JustGiving charges | 216 | 216 |
| Governance costs | 231 | 231 |
| Accountancy and legal fees | 571 | 513 |
| Total resources expended | 20,639 | 11,727 |
| Net income/(expenditure) | 49,113 | (6,263) |
This page does not form part of the statutory financial statements
Page 8